Table 1.
Combined group (n = 25) | Control group (n = 17) | χ 2/P | |
---|---|---|---|
Male/female(case) | 14/11 | 10/7 | 0.325 |
Age(years) | 69.32 ± 5.00 | 68.71 ± 4.06 | 0.068 |
Myeloma types IgG/IgA/light chain (case) | 11/8/6 | 7/5/5 | 0.765 |
ISS (International Staging) stage I/stage IIA/stage IIIA/stage IIIB (case) | 6/7/8/4 | 4/5/4/4 | 0.059 |